T 1241/03 (Human growth hormone/GENENTECH) of 01.09.2005
- European Case Law Identifier
- ECLI:EP:BA:2005:T124103.20050901
- Date of decision
- 1 September 2005
- Case number
- T 1241/03
- Petition for review of
- -
- Application number
- 93918499.0
- IPC class
- A61K 38/27A61K 47/26A61K 47/10
- Language of proceedings
- English
- Distribution
- Distributed to board chairmen (C)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Human growth hormone aqueous formulation
- Applicant name
- GENENTECH, INC.
- Opponent name
- 01. Grandis Biotech GmbH
02. Novo Nordisk A/S - Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 123(2) 1973European Patent Convention Art 56 1973European Patent Convention Art 83 1973
- Keywords
- Main request, auxiliary requests 1 and 4 - sufficiency of disclosure (no)
Auxiliary request 2 - admissibility (no)
Auxiliary request 3 - inventive step (no)
Ultimate claim request - added subject-matter (no), sufficiency, novelty, inventive step (yes) - Catchword
- -
ORDER
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the department of the first instance with the order to maintain the patent on the basis of the claim 1 of the "ultimate claim request" filed with the letter of 18 August 2005 and a description to be adapted thereto.